The content is available as a PDF (210.0 KB).
letter . 2020 Apr 21:hcaa137. doi: 10.1093/qjmed/hcaa137
Eosinophil count in severe coronavirus disease 2019 (COVID-19)
Giuseppe Lippi
h1,✉, Brandon M Henry
h2
Giuseppe Lippi
h1Section of Clinical Biochemistry, University of Verona, Verona, Italy
Find articles by Giuseppe Lippi
Brandon M Henry
h2Cardiac Intensive Care Unit, The Heart Institute, Cincinnati Children’s Hospital Medical Center, Ohio, USA
Find articles by Brandon M Henry
h1Section of Clinical Biochemistry, University of Verona, Verona, Italy
h2Cardiac Intensive Care Unit, The Heart Institute, Cincinnati Children’s Hospital Medical Center, Ohio, USA
✉
Corresponding Author: Prof. Giuseppe Lippi, Section of Clinical Biochemistry, University Hospital of Verona, Piazzale LA Scuro, 37134 Verona, Italy, Tel. +39-045-8124308, Fax. +39-045-8122970, Email: giuseppe.lippi@univr.it
Received 2020 Mar 20; Accepted 2020 Mar 27.
Keywords: coronavirus, COVID-19, eosinopenia, eosinophils
© The Author(s) 2020. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oup.com
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
PMCID: PMC7188135 PMID: 32315429